AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 8489087
Drug: Gentamicin admixed
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gentamicin admixed with clindamycin 900 mg IVPB every 8 hours (Group I n = 80)
Trial: 2674460
Drug: 60 mg
RxNorm normalized name: opium 60 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 60 mg of cisplatin (CDDP)/m2
Trial: 2674460
Drug: 150 mg
RxNorm normalized name: pectin 150 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 150 mg of carboplatin (CBDCA)/m2
Trial: 31122824
Drug: Protocol C
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Protocol C (Moviprep® after capsule arrival)
Trial: 24013058
Drug: Mipomersen 200
RxNorm normalized name: mipomersen 200 mg/mL subcutaneous solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mipomersen 200 mg weekly for 26 weeks
Trial: 25394366
Drug: Sequential pattern
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sequential pattern recognition control
Trial: 23546562
Drug: Control (24
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (24 weeks of monthly weigh-ins)
Trial: 20951487
Drug: Cinacalcet plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cinacalcet plus low-dose activated vitamin D analogues (Cinacalcet-D)
Trial: 7543713
Drug: Low-dose heparin
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose heparin (5000 units 2 hours before operation and 5000 units every 8 hours for 5 days after operation)
Trial: 7543713
Drug: Dextran 40
RxNorm normalized name: Dextran 40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dextran 40 (administered during the operation with an additional infusion of 500 ml/day for the next 3 days)
Trial: 2795401
Drug: Parent absent
RxNorm normalized name: C.I. direct red 28 parent
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Parent absent during injection
Trial: 24740662
Drug: High-dosage tamoxifen
RxNorm normalized name: hepatitis B surface antigen vaccine
DrugBank: Hepatitis B Vaccine (Recombinant) (DB11627)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dosage tamoxifen (80 mg/day) administered from six weeks prior until twelve weeks after surgery
Trial: 22147649
Drug: MDX-1100 (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MDX-1100 (10 mg/kg every other week)
Trial: 16334120
Drug: Weekly 1‐h
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Weekly 1‐h or 3‐h infusions of paclitaxel
Trial: 11986448
Drug: Budesonide inhalation
RxNorm normalized name: Budesonide Inhalation Powder
DrugBank: Budesonide (DB01222)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Budesonide inhalation suspension, 0.5 mg daily (n = 168)
Trial: 9535299
Drug: Minimal therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Minimal therapy (control)
Trial: 7893023
Drug: edrophonium 1
RxNorm normalized name: edrophonium 10 mg/mL injectable solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: edrophonium 1 mg/kg + atropine 10 micrograms/kg, i.v.
Trial: 27576860
Drug: CLT-28643 (single
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CLT-28643 (single subconjunctival injection intraoperatively) followed by postoperative vehicle eye drops (CLT+ group)
Trial: 21494892
Drug: Tapentadol IR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tapentadol IR 75 mg
Trial: 26293513
Drug: Tapentadol IR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tapentadol IR (50 and 75 mg)
Trial: 21928240
Drug: Brachial plexus
RxNorm normalized name: Brachial Plexus Tray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Brachial plexus block (BPB) with 15 mL ropivacaine 1% and 10 mL saline via axillary approach
Trial: 17463075
Drug: TENS application
RxNorm normalized name: TEN
DrugBank: Pentaerythritol tetranitrate (DB06154)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TENS application for 60 minutes daily
Trial: 17463075
Drug: TENS application
RxNorm normalized name: TEN
DrugBank: Pentaerythritol tetranitrate (DB06154)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TENS application for 8 hours daily
Trial: 18728907
Drug: 2.5 hours
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2.5 hours of weekly, mandatory physical exercise of middle-to-high intensity
Trial: 18728907
Drug: Reduction of
RxNorm normalized name: reductic acid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Reduction of full-time weekly workhours from 40 to 37.5 hours
Trial: 10234600
Drug: Argatroban 1
RxNorm normalized name: argatroban 1 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Argatroban 1 microgram/kg/min infused on day 6 of a 7-day oral regimen of 500 mg erythromycin four times daily (regimen B)
Trial: 1534993
Drug: 3 micrograms/ml
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3 micrograms/ml sufentanil in saline (Group S)
Trial: 1534993
Drug: 1.5 micrograms/ml
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.5 micrograms/ml sufentanil in 0.125% bupivacaine (Group SB)
Trial: 3456271
Drug: Doxorubicin (75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Doxorubicin (75 mg/m2 iv every 3 weeks)
Trial: 3456271
Drug: Epirubicin (75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epirubicin (75 mg/m2 iv every 3 weeks)
Trial: 18231884
Drug: Sterile water
RxNorm normalized name: sterile water
DrugBank: Water (DB09145)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sterile water injections
Trial: 15662234
Drug: Up-titrated candesartan
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Up-titrated candesartan (12 mg/day) monotherapy
Trial: 12693152
Drug: Intramuscular HBV
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular HBV vaccine (20 micrograms each dose) at 0, 1, and 6 month intervals
Trial: 12693152
Drug: Intradermal HBV
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intradermal HBV vaccine (2 micrograms each dose) at 0, 1, and 6 month intervals
Trial: 31377160
Drug: Hormone Therapy
RxNorm normalized name: INVESTIGATIONAL HORMONE THERAPY/REPLACEMENT,OTHER
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hormone Therapy (HT) alone
Trial: 28647759
Drug: Weekly mailings
RxNorm normalized name: tobramycin
DrugBank: Tobramycin (DB00684)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Weekly mailings of parenting information (control)
Trial: 9568453
Drug: Enalapril 2.5
RxNorm normalized name: enalapril 2.5 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enalapril 2.5 mg twice daily
Trial: 7778530
Drug: Enalapril 5
RxNorm normalized name: enalapril 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enalapril 5 mg twice daily
Trial: 30516797
Drug: Sertraline plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sertraline plus enhanced medication management
Trial: 29189347
Drug: Exenatide (17.4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Exenatide (17.4 μg infusion for 6 hours and 15 minutes)
Trial: 26690312
Drug: Latest generation
RxNorm normalized name: regenerated cellulose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Latest generation drug-eluting stent (SYNERGY™ II; Boston Scientific)
Trial: 23032073
Drug: ABT-894 (4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ABT-894 (4 mg BID)
Trial: 23032073
Drug: Atomoxetine (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atomoxetine (40 mg BID)
Trial: 16152838
Drug: Vertebral manipulation
RxNorm normalized name: Sus scrofa cerebral cortex preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vertebral manipulation (VM) therapy
Trial: 10488597
Drug: Glutamine (0.3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Glutamine (0.3 g/kg enterally for 5 days)
Trial: 10488597
Drug: Casein (0.3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Casein (0.3 g/kg enterally for 5 days)
Trial: 8561067
Drug: 100 g
RxNorm normalized name: Berri-Freez 4.5 GM per 100 GM
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 g butter
Trial: 8561067
Drug: 50 g
RxNorm normalized name: glucose 50 g/296 mL oral liquid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 g butter
Trial: 1877740
Drug: Disulfiram (DS)
RxNorm normalized name: Disulfiram
DrugBank: Disulfiram (DB00822)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Disulfiram (DS) implant (10 x 100 mg DS tablets)
Trial: 1877740
Drug: Disulfiram (DS)
RxNorm normalized name: Disulfiram
DrugBank: Disulfiram (DB00822)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Disulfiram (DS) implant
Trial: 1877740
Drug: Placebo (9
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (9 x 100 mg calcium phosphate tablets + 1 mg DS tablet)
Trial: 1888621
Drug: Diclofenac gel
RxNorm normalized name: diclofenac Topical Gel
DrugBank: Diclofenac (DB00586)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Diclofenac gel
Trial: 1903813
Drug: Phenothrin lotion
RxNorm normalized name: phenothrin Topical Lotion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Phenothrin lotion
Trial: 9726802
Drug: ACE inhibitors
RxNorm normalized name: ACE INHIBITORS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ACE inhibitors (captopril 25 to 50 mg daily or enalapril 10 to 40 mg daily)
Trial: 19759043
Drug: Once-daily dosing
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Once-daily dosing (ODD) of gentamicin
Trial: 19759043
Drug: Multiple daily
RxNorm normalized name: Multivitamin Oral Tablet [MULTIPLE DAILY W/BETA]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Multiple daily dosing (MDD) of gentamicin
Trial: 17726314
Drug: Moderate beer
RxNorm normalized name: BEER
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Moderate beer consumption (330 ml for women and 660 ml for men) for 30 days
Trial: 16335304
Drug: Cytokines with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cytokines with antimicrobial agents
Trial: 9501404
Drug: IVIG infusion
RxNorm normalized name: Duo Fusion
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: IVIG infusion rate of 0.08 ml/kg/min
Trial: 9501404
Drug: IVIG infusion
RxNorm normalized name: Duo Fusion
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: IVIG infusion rate of 0.06 ml/kg/min
Trial: 9501404
Drug: IVIG infusion
RxNorm normalized name: Duo Fusion
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: IVIG infusion rate of 0.04 ml/kg/min
Trial: 7995386
Drug: 0.1 mg
RxNorm normalized name: biotin 0.1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.1 mg ANP inhalation
Trial: 7995386
Drug: 1 mg
RxNorm normalized name: biotin 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg ANP inhalation
Trial: 7995386
Drug: 5 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg ANP inhalation
Trial: 2457768
Drug: Captopril 1
RxNorm normalized name: captopril 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Captopril 1 mg
Trial: 2457768
Drug: Captopril 5
RxNorm normalized name: captopril 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Captopril 5 mg
Trial: 21748252
Drug: ABT-089 40
RxNorm normalized name: ABT-925
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ABT-089 40 mg QD
Trial: 21748252
Drug: ABT-089 40
RxNorm normalized name: ABT-925
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ABT-089 40 mg BID
Trial: 21748252
Drug: ABT-089 (all
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ABT-089 (all doses)
Trial: 16098001
Drug: Omeprazole 20
RxNorm normalized name: omeprazole 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omeprazole 20 mg b.d. (OCM group)
Trial: 12182969
Drug: Pilocarpine (5-mg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pilocarpine (5-mg tablets) three times daily for 1 month after treatment
Trial: 12182969
Drug: Placebo three
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo three times daily for 1 month after treatment
Trial: 23336124
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group observed the affected hand instead of using mirror therapy
Trial: 1548648
Drug: Controlled-release ketoprofen
RxNorm normalized name: ketoprofen Extended Release Oral Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Controlled-release ketoprofen
Trial: 15699225
Drug: Statin diet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Statin diet (20 mg lovastatin)
Trial: 12971709
Drug: General programme
RxNorm normalized name: PUMP,LUTREPULSE PROGRAMMABLE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: General programme of psychomotor therapy
Trial: 30466402
Drug: Oxytocin (8.3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxytocin (8.3 μg or 5 U)
Trial: 15871654
Drug: Evidence-based medicine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Evidence-based medicine (EBM) methods applied to drug utilization patterns
Trial: 12196660
Drug: 10 g
RxNorm normalized name: Co Q-10 Gummies
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 g Semmes‐Weinstein monofilament (touch/pressure sensation)
Trial: 11083193
Drug: Intravenous nicorandil
RxNorm normalized name: nicorandil
DrugBank: Nicorandil (DB09220)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous nicorandil (4 mg in 5 minutes at admission, followed by 6 mg/hr over 24 hours)
Trial: 9437273
Drug: Paracetamol-dextropropoxyphene
RxNorm normalized name: dextropropoxyphene
DrugBank: Dextropropoxyphene (DB00647)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Paracetamol-dextropropoxyphene
Trial: 3021501
Drug: Nedocromil sodium
RxNorm normalized name: Nedocromil Sodium
DrugBank: Nedocromil (DB00716)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nedocromil sodium 4 mg q.i.d.
Trial: 3021499
Drug: Nedocromil sodium
RxNorm normalized name: Nedocromil Sodium
DrugBank: Nedocromil (DB00716)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nedocromil sodium 2 mg q.i.d.
Trial: 22490901
Drug: HNIPPV plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HNIPPV plus tiotropium bromide and doxofylline tablets
Trial: 22490901
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (tiotropium bromide, doxofylline tablets, and low-flow inhalation of oxygen)
Trial: 18589554
Drug: Daidzein dripping
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daidzein dripping pills (50 mg)
Trial: 18589554
Drug: Daidzein tablets
DrugBank: Daidzein (DB13182)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daidzein tablets (50 mg)
Trial: 16078335
Drug: Ketoprofen 100
RxNorm normalized name: ketoprofen 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketoprofen 100 mg patch
Trial: 12375713
Drug: Albuterol (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Albuterol (200 microg, 2 inhalations via MDI with spacer)
Trial: 1874224
Drug: Stepwise rising
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Stepwise rising propofol infusion regime of 0.24, 0.6 and 1.5 mg kg‐1 h‐1 for 75 min (25 min at each infusion rate)
Trial: 19631948
Drug: Fluoxetine 20mg
RxNorm normalized name: fluoxetine 20 MG
DrugBank: Fluoxetine (DB00472)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Fluoxetine 20mg
Trial: 28463874
Drug: Conjugated estrogens/bazedoxifene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conjugated estrogens/bazedoxifene 0.45 mg/20 mg
Trial: 28463874
Drug: Conjugated estrogens/bazedoxifene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conjugated estrogens/bazedoxifene 0.625 mg/20 mg
Trial: 24748629
Drug: blisibimod 200
RxNorm normalized name: Blisibimod
DrugBank: Blisibimod (DB12330)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: blisibimod 200 mg once-weekly (QW)
Trial: 20237929
Drug: Spa therapy
RxNorm normalized name: Broda Acne Spa
DrugBank: Salicylic acid (DB00936)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Spa therapy (daily locally applied mud‐packs and bicarbonate‐sulphate mineral bath water)
Trial: 19661449
Drug: Aminophylline (adenosine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aminophylline (adenosine receptor antagonist)
Trial: 21444699
Drug: MP-376 (levofloxacin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MP-376 (levofloxacin inhalation solution) 180 mg
Trial: 21444699
Drug: MP-376 (levofloxacin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MP-376 (levofloxacin inhalation solution) 240 mg
Trial: 21444699
Drug: MP-376 (levofloxacin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MP-376 (levofloxacin inhalation solution)
Trial: 8620638
Drug: Physical therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Physical therapy program (Group 2) designed to strengthen upper and lower limbs and improve knee range of motion
Trial: 8620638
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (Group 1) with no preoperative physical therapy
Trial: 1458033
Drug: Bromocriptine (1.25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bromocriptine (1.25 mg bid)
Trial: 6393460
Drug: Low dose
RxNorm normalized name: Low Dose ASA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dose oral contraceptive
Trial: 6393460
Drug: Standard dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard dose oral contraceptive
Trial: 29325799
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of HCY and hs-CRP
Trial: 24618303
Drug: Montelukast tablets
RxNorm normalized name: montelukast Chewable Tablet
DrugBank: Montelukast (DB00471)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Montelukast tablets and fluticasone propionate nasal spray (n = 64)
Trial: 12823079
Drug: Sertraline (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sertraline (50 to 100 mg daily)
Trial: 12823079
Drug: Imipramine (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Imipramine (100 to 200 mg daily)
Trial: 1996743
Drug: Chloroquine (weekly
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chloroquine (weekly for four weeks)
Trial: 1996743
Drug: Chloroquine and
RxNorm normalized name: chloroquine and proguanil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chloroquine and No drug (both groups)
Trial: 25753207
Drug: 1 g
RxNorm normalized name: Molds 1 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 g aspirin
Trial: 19018783
Drug: Low-dose pioglitazone
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose pioglitazone (7.5 mg/day; 21/28 days)
Trial: 9752892
Drug: Amlodipine (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amlodipine (5 to 10 mg)
Trial: 11287711
Drug: Enoxaparin 1.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enoxaparin 1.0 mg/kg intravenously (without abciximab)
Trial: 11287711
Drug: Reduced dose
RxNorm normalized name: Iron, reduced
DrugBank: Iron (DB01592)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Reduced dose enoxaparin 0.75 mg/kg in combination with standard-dose abciximab intravenously during PCI
Trial: 9505993
Drug: Oral administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral administration of valspodar (400 mg as microemulsion soft gelatin capsules)
Trial: 7939618
Drug: Lead in
RxNorm normalized name: lead
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lead in air (PbA) in the administration area: 4.2 micrograms/m3
Trial: 29504666
Drug: Weekly phone
RxNorm normalized name: tobramycin
DrugBank: Tobramycin (DB00684)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Weekly phone call feedback for control group caregivers.
Trial: 16449396
Drug: Evidence-based collaborative
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Evidence-based collaborative depression treatment (pharmacotherapy, problem-solving treatment, or both)
Trial: 10718681
Drug: Lamotrigine (LTG)
RxNorm normalized name: Lamotrigine
DrugBank: Lamotrigine (DB00555)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Lamotrigine (LTG) 300 mg/day for 3 months
Trial: 3944270
Drug: TxB2 infusion
RxNorm normalized name: Duo Fusion
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: TxB2 infusion at 1.0 ng/kg X min
Trial: 30354330
Drug: GIST (Genotype
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GIST (Genotype Informed Statin Therapy)
Trial: 27289365
Drug: TFMPP (60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TFMPP (60 mg)
Trial: 27289365
Drug: Dexamphetamine (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexamphetamine (20 mg)
Trial: 26630992
Drug: Benzylpiperazine (BZP)
RxNorm normalized name: cinnamido benzylpiperidinyl ethoxypropylbenzamide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Benzylpiperazine (BZP) (200 mg)
Trial: 26630992
Drug: BZP +
RxNorm normalized name: Benzylpiperazine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BZP + TFMPP (100/30 mg)
Trial: 25518117
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group treated by injection of 10 mg of Metoclopramide into the deltoid muscle and gluteus maximus muscle
Trial: 14604244
Drug: Standard single
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard single prebypass heparin dose (300 IU/kg)
Trial: 25725625
Drug: Ephedrine 1.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ephedrine 1.5 mg kg(‐1) day(‐1) for 28 days
Trial: 25725625
Drug: Acute ephedrine
RxNorm normalized name: Ephedrine
DrugBank: Ephedrine (DB01364)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Acute ephedrine (2.5 mg/kg) after 28 days of treatment
Trial: 23551710
Drug: Trivalent influenza
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trivalent influenza virus vaccine (TIV) in pregnant women
Trial: 30136707
Drug: Clarithromycin tablet
RxNorm normalized name: Clarithromycin Tablets
DrugBank: Clarithromycin (DB01211)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Clarithromycin tablet at 250 mg once daily for 3 months